CASC
State Street’s Cascadian Therapeutics, Inc. CASC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-511,169
| Closed | -$1.89M | – | 3813 |
|
|
2017
Q4 | $1.89M | Buy |
511,169
+57,061
| +13% | +$211K | ﹤0.01% | 3205 |
|
|
2017
Q3 | $1.86M | Buy |
454,108
+42,809
| +10% | +$175K | ﹤0.01% | 3235 |
|
|
2017
Q2 | $1.53M | Buy |
411,299
+377,410
| +1,114% | +$1.4M | ﹤0.01% | 3238 |
|
|
2017
Q1 | $140K | Buy |
33,889
+22,700
| +203% | +$93.8K | ﹤0.01% | 3527 |
|
|
2016
Q4 | $47K | Sell |
11,189
-55,951
| -83% | -$235K | ﹤0.01% | 3567 |
|
|
2016
Q3 | $109K | Hold |
67,140
| – | – | ﹤0.01% | 3442 |
|
|
2016
Q2 | $63K | Sell |
67,140
-1,560,565
| -96% | -$1.46M | ﹤0.01% | 3574 |
|
|
2016
Q1 | $2.06M | Buy |
1,627,705
+7,841
| +0.5% | +$9.94K | ﹤0.01% | 2994 |
|
|
2015
Q4 | $3.6M | Buy |
1,619,864
+37,171
| +2% | +$82.6K | ﹤0.01% | 2714 |
|
|
2015
Q3 | $4.34M | Buy |
1,582,693
+174,144
| +12% | +$477K | ﹤0.01% | 2592 |
|
|
2015
Q2 | $5.27M | Buy |
1,408,549
+440,333
| +45% | +$1.65M | ﹤0.01% | 2596 |
|
|
2015
Q1 | $1.58M | Buy |
968,216
+215,078
| +29% | +$351K | ﹤0.01% | 3107 |
|
|
2014
Q4 | $1.43M | Buy |
753,138
+24,519
| +3% | +$46.6K | ﹤0.01% | 3163 |
|
|
2014
Q3 | $1.4M | Buy |
728,619
+70,448
| +11% | +$135K | ﹤0.01% | 3157 |
|
|
2014
Q2 | $2.13M | Buy |
658,171
+629,031
| +2,159% | +$2.04M | ﹤0.01% | 3041 |
|
|
2014
Q1 | $87K | Hold |
29,140
| – | – | ﹤0.01% | 3513 |
|
|
2013
Q4 | $51K | Hold |
29,140
| – | – | ﹤0.01% | 3536 |
|
|
2013
Q3 | $61K | Sell |
29,140
-500
| -2% | -$1.05K | ﹤0.01% | 3504 |
|
|
2013
Q2 | $46K | Buy |
+29,640
| New | +$46K | ﹤0.01% | 3455 |
|